Safari 2 G Insecticide

SECTION 2: Hazards identification

EMERGENCY OVERVIEW Note: • No signal word required.

Potential health effects

Acute Toxicity (Primary Routes of Exposure) Signs and Symptoms of Systemic Effects: No significant signs of systemic toxicity were observed in animals exposed to very high oral, dermal or inhalation dosages of Dinotefuran Technical. The toxicity of this formulation has not been fully assessed. The information provided is based on a similar product. Acute Eye Contact: This product is expected to cause minimal or no eye irritation. The expected adverse health effects resulting from an exposure may include redness and possibly some minor swelling. Acute Skin Contact: This product can cause brief and/or minor irritation. The expected adverse health effects resulting from an exposure may include redness and possibly some minor swelling. This product is slightly toxic when absorbed through the skin. This product is not expected to cause allergic skin reactions. Acute Ingestion: This product is slightly toxic when ingested. Acute Inhalation: This product is minimally toxic when inhaled. Chronic Toxicity (including cancer): No specific target organ(s) could be identified in chronic studies conducted with Dinotefuran in rats, mice and dogs, nor did it produce tumors in rats or mice. This product contains an unknown quanity of crystalline silica, which is listed by IARC as a carconigen and may contain wood dust, which is listed by IARC as a carcinogen and by NTP as a known carcinogen. Developmental Toxicity (birth defects): No developmental toxicity was produced in animals exposed to Dinotefuran Technical, even at doses that were toxic to the pregnant animal. Reproductive Toxicity: Dinotefuran Technical was tested in a two-generation rat reproduction study. Reduced preweaning weight gain was observed only at a dose that also produced systemic maternal toxicity. Potentially Aggravated Medical Conditions: None known For complete discussion of the toxicology data from which this evaluation was made, refer to Section 11. For Regulatory Information, refer to Section 15.